[
    [
        {
            "time": "",
            "original_text": "【浙商医药|孙建】周报：‘恐高’回调，坚守主线",
            "features": {
                "keywords": [
                    "恐高",
                    "回调",
                    "坚守",
                    "主线"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【浙商医药|孙建】周报：‘恐高’回调，坚守主线",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "CXO产业图谱(一)：需求强劲 小分子CDMO崛起",
            "features": {
                "keywords": [
                    "CXO",
                    "产业图谱",
                    "需求强劲",
                    "小分子CDMO",
                    "崛起"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "CXO产业图谱(一)：需求强劲 小分子CDMO崛起",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "制药行业一周风云榜：未见开门红，CRO触底反弹，君实生物PD-1获批新适应症",
            "features": {
                "keywords": [
                    "制药行业",
                    "开门红",
                    "CRO",
                    "触底反弹",
                    "君实生物",
                    "PD-1",
                    "新适应症"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "制药行业一周风云榜：未见开门红，CRO触底反弹，君实生物PD-1获批新适应症",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]